Capon, S. J.; Maroufidou, A.; Feltes, M.; Xu, Y.; Matharoo, D. K.; Juelich, D.; Holley, S. A.; Farber, S. A.; Stainier, D. Y. R.: A genetic modifier links integrin α5 to the phenotypic variation in fibronectin 1a mutant zebrafish. PLOS GENETICS 21 (6), e1011747 (2025)
Researchers at the Max Planck Institute develop a new pharmacological approach that specifically targets receptor interactions – with implications for immune defense and blood pressure regulation
A team of researchers at the Max Planck Institute for Heart and Lung Research, led by Prof. Dr. Didier Y.R. Stainier, has been awarded a prestigious ERC Proof of Concept (PoC) grant to advance a groundbreaking RNA-based therapeutic strategy for Duchenne Muscular Dystrophy (DMD).